200
Participants
Start Date
August 30, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Clinical outcomes of patients with VWD, Type 1
Accumulate information regarding bleeding events, quality of life, and the social and clinical impact of bleeding events in participants with VWD, Type 1
Clinical outcomes of patients with VWD, Type 2A, Type 2M, Type 2N, or Type 3
Accumulate information regarding bleeding events, quality of life, and the social and clinical impact of bleeding events in participants with VWD, Type 2A, Type 2M, Type 2N and Type 3.
RECRUITING
Emory Children's Center, Atlanta
RECRUITING
University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami
RECRUITING
Innovative Hematology, Inc./Indiana Hemophilia and Thrombosis Center, Indianapolis
RECRUITING
University of Michigan Hospitals, Department of Hemophilia and Coagulation Disorders, Ann Arbor
NOT_YET_RECRUITING
Mayo Clinic - Rochester, Rochester
RECRUITING
The University of Texas Southwestern Medical Center, Dallas
RECRUITING
Phoenix Children's Hospital, Phoenix
RECRUITING
Washington Institute For Coagulation (WIC), Seattle
RECRUITING
Arkansas Children's Hospital, Little Rock
RECRUITING
Tulane University School of Medicine, New Orleans
NOT_YET_RECRUITING
Oregon Health & Science University, Portland
RECRUITING
Fiona Stanley Hospital, Murdoch
RECRUITING
Royal Prince Alfred Hospital, Camperdown
RECRUITING
The Alfred Hospital, Melbourne
RECRUITING
Richmond Pharmacology, London
Hemab ApS
INDUSTRY